SEARCH

SEARCH BY CITATION

References

  • Apparsundaram S., Galli A., DeFelice L. J., Hartzell H. C. and Blakely R. D. (1998) Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp Therapeutics 287, 733743.
  • Apparsundaram S., Sung U. H., Price R. D. and Blakely R. D. (2001) Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J. Pharmacol. Exp Therapeutics 299, 666677.
  • Banks W. A. and Kastin A. J. (1998) Differential permeability of the blood–brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19, 883889.
  • Baserga R., Hongo A., Rubini M., Prisco M. and Valentinis B. (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochimica Biophysica Acta 1332, F105F126.
  • Batchelor M. and Schenk J. O. (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18, 1030410309.
  • Beckman M. L. and Quick M. W. (1998) Neurotransmitter transporters: regulators of function and functional regulation. J. Membrane Biol. 164, 110.DOI: 10.1007/s002329900388
  • Bergstedt K. and Wieloch T. (1993) Changes in insulin-like growth factor 1 receptor density after transient cerebral ischemia in the rat. Lack of protection against ischemic brain damage following injection of insulin-like growth factor 1. J. Cereb. Blood Flow Metab. 13, 895898.
  • Blakely R. D. and Bauman A. (2000) Biogenic amine transporters: regulation in flux. Curr. Opn. Neurobiol. 10, 328336.
  • Boyd F. T. Jr, Clarke D. W. and Raizada M. K. (1986) Insulin inhibits specific norepinephrine uptake in neuronal cultures from rat brain. Brain Res. 398, 15.
  • Carr K. D., Kim G. and Cabeza de Vaca S. (2000) Hypoinsulinemia may mediate the lowering of self-stimulation thresholds by food restriction and streptozotocin-induced diabetes. Brain Res. 863, 160168.
  • Cheatham B. and Kahn C. R. (1995) Insulin action and the insulin signaling network. Endocrine Rev. 16, 117142.
  • Ciliax B. J., Drash G. W., Staley J. K., Haber S., Mobley C. J., Miller G. W., Mufson E. J., Mash D. C. and Levey A. I. (1999) Immunocytochemical localization of the dopamine transporter in human brain. J. Comparative Neurol. 409, 3856.
  • Ciliax B. J., Heilman C., Demchyshyn L. L., Pristupa Z. B., Ince E., Hersch S. M., Niznik H. B. and Levey A. I. (1995) The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15, 17141723.
  • Clarke J. F., Young P. W., Yonezawa K., Kasuga M. and Holman G. D. (1994) Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300, 631635.
  • Damke H., Baba T., Warnock D. E. and Schmid S. L. (1994) Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 127, 915934.
  • Daniels G. M. and Amara S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 3579435801.
  • Davis K. E., Straff D. J., Weinstein E. A., Bannerman P. G., Correale D.  M., Rothstein J. D. and Robinson M. B. (1998) Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma. J. Neurosci. 18, 24752485.
  • Doolen S. and Zahniser N. R. (2001) Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J. Pharmacol. Exp. Ther. 296, 931938.
  • Elmendorf J. S. and Pessin J. E. (1999) Insulin signaling regulating the trafficking and plasma membrane fusion of GLUT4-containing intracellular vesicles. Exp. Cell Res. 253, 5562.DOI: 10.1006/excr.1999.4675
  • Ferrer J. V. and Javitch J. A. (1998) Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proc. Natl Acad. Sci. USA 95, 92389243.
  • Figlewicz D. P. (1999) Endocrine regulation of neurotransmitter transporters. Epilepsy Res. 37, 203210.
  • Fumagalli F., Jones S., Bosse R., Jaber M., Giros B., Missale C., Wightman R. M. and Caron M. G. (1998) Inactivation of the dopamine transporter reveals essential roles of dopamine in the control of locomotion, psychostimulant response, and pituitary function. Adv. Pharmacol. (New York) 42, 179182.
  • Giros B. and Caron M. G. (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 4349.
  • Giros B., El Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T. and Caron M. G. (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42, 383390.
  • Grace A. A. (1995) The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Dependence 37, 111129.
  • Hyman S. E. (1996) Addiction to cocaine and amphetamine. Neuron 16, 901904.
  • James D. E. and Piper R. C. (1994) Insulin resistance, diabetes, and the insulin-regulated trafficking of GLUT-4. J. Cell Biol. 126, 11231126.
  • Jones S. R., Gainetdinov R. R., Wightman R. M. and Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 19791986.
  • Katagiri H., Asano T., Inukai K., Ogihara T., Ishihara H., Shibasaki Y., Murata T., Terasaki J., Kikuchi M., Yazaki Y. and Oka Y. (1997) Roles of PI 3-kinase and Ras on insulin-stimulated glucose transport in 3T3-L1 adipocytes. Am. J. Physiol. 272, E326E331.
  • Katagiri H., Asano T., Ishihara H., Inukai K., Shibasaki Y., Kikuchi M., Yazaki Y. and Oka Y. (1996) Overexpression of catalytic subunit p110alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J. Biol. Chem. 271, 1698716990.
  • Law R. M., Stafford A. and Quick M. W. (2000) Functional regulation of gamma-aminobutyric acid transporters by direct tyrosine phosphorylation. J. Biol. Chem. 275, 2398623991.
  • Liu Y., Krantz D. E., Waites C. and Edwards R. H. (1999) Membrane trafficking of neurotransmitter transporters in the regulation of synaptic transmission. Trends Cell Biol. 9, 356363.
  • Manzanares J., Canton R., Grande C., Benedi J. and Zaragoza F. (1988) Levels of insulin in the brains of rats modified by chronic administration of amphetamine, haloperidol and sulpiride. Neuropharmacol. 27, 11411144.
  • Marshall J. F. (1978) Further analysis of the resistance of the diabetic rat to d-amphetamine. Pharm. Biochem. Behav. 8, 281286.
  • Mayfield R. D. and Zahniser N. R. (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol. Pharmacol. 59, 113121.
  • Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 76997710.
  • Patterson T. A., Brot M. D., Zavosh A., Schenk J. O., Szot P. and Figlewicz D. P. (1998) Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68, 1120.
  • Pilotte N. S., Sharpe L. G. and Kuhar M. J. (1994) Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Therap. 269, 963969.
  • Pristupa Z. B., McConkey F., Liu F., Man H. Y., Lee F. J., Wang Y. T. and Niznik H. B. (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30, 7987.DOI: 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I
  • Qian Y., Galli A., Ramamoorthy S., Risso S., DeFelice L. J. and Blakely R. D. (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17, 4557.
  • Raizada M. K., Shemer J., Judkins J. H., Clarke D. W., Masters B. A and LeRoith D (1988) Insulin receptors in the brain: structural and physiological characterization. Neurochemical Research 13,297303.
  • Ramamoorthy S. and Blakely R. D. (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285, 763766.DOI: 10.1126/science.285.5428.763
  • Rees S., Coote J., Stables J., Goodson S., Harris S. and Lee M. G. (1996) Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques 20, 102104.
  • Rowland N., Joyce J. N. and Bellush L. L. (1985) Stereotyped behavior and diabetes mellitus in rats: reduced behavioral effects of amphetamine and apomorphine and reduced in vivo brain binding of [3H]spiroperidol. Behav. Neurosci. 99, 831841.
  • Saitoh A., Morita K., Sodeyama M. and Kamei J. (1998) Effects of the experimental diabetes on dopamine D1 receptor-mediated locomotor-enhancing activity in mice. Pharmacol. Biochem. Behav 60, 161166.
  • Saunders C., Ferrer J. V., Shi L., Chen J., Merrill G., Lamb M. E., Leeb-Lundberg L. M. F., Carvelli L., Javitch J. A. and Galli A. (2000) Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. 97, 68506855.
  • Schulingkamp R. J., Pagano T. C., Hung D. and Raffa R. B. (2000) Insulin receptors and insulin action in the brain: review and ssclinical implications. Neurosci. Biobehavioral Rev. 24, 855872.
  • Toews M. L., Waldo G. L., Harden T. K. and Perkins J. P. (1984) Relationship between an altered membrane form and a low affinity form of the beta-adrenergic receptor occurring during catecholamine-induced desensitization. Evidence for receptor internalization. J. Biol. Chem. 259, 1184411850.
  • Vaughan R. A., Huff R. A., Uhl G. R. and Kuhar M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 1554115546.
  • Zhang L., Coffey L. L. and Reith M. E. (1997) Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem. Pharmacol. 53, 677688.
  • Zhang J., Ferguson S. S. G., Barak L. S., Menard L. and Caron M. G. (1996) Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J. Biol. Chem. 271, 1830218305.
  • Zhu S. J., Kavanaugh M. P., Sonders M. S., Amara S. G. and Zahniser N. R. (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J. Pharmacol. Exp Therap. 282, 13581365.